A 14-mo zinc-supplementation trial in apparently healthy chilean preschool children
Author
dc.contributor.author
Ruz, Manuel
Author
dc.contributor.author
Castillo-Duran, Carlos
Author
dc.contributor.author
Lara, Ximena
Author
dc.contributor.author
Codoceo, Juana
Author
dc.contributor.author
Rebolledo, Annabella
Author
dc.contributor.author
Alalah, Eduardo
Admission date
dc.date.accessioned
2019-01-29T15:32:11Z
Available date
dc.date.available
2019-01-29T15:32:11Z
Publication date
dc.date.issued
1997
Cita de ítem
dc.identifier.citation
American Journal of Clinical Nutrition, Volumen 66, Issue 6, 2018, Pages 1406-1413
Identifier
dc.identifier.issn
00029165
Identifier
dc.identifier.other
10.1093/ajcn/66.6.1406
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/161582
Abstract
dc.description.abstract
Apparently healthy preschool children (46 boys, 52 girls) aged 27-50 mo from low socioeconomic conditions who attended daycare centers in Santiago participated in a 14-mo long double-blind zinc supplementation trial. Unlike most previous studies, no additional inclusion criteria such as short stature or slow growth rate were considered. Subjects were pair matched according to sex and age and randomly assigned to two experimental groups: the supplemented group, which received 10 mg Zn/d, and the placebo group. Selected anthropometric, clinical, dietary, biochemical, and functional indexes were determined at the beginning of the study and after 6 and 14 mo of intervention. Actual dietary zinc intake was 66% of the recommended dietary allowance. Height gain after 14 mo was on average 0.5 cm higher in the supplemented group (P = 0.10). The response, however, was different between sexes. Boys from the supplemented group gained 0.9 cm more than those in the placebo group (P = 0.045). No effe